Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alpha Cognition Inc. (ACOG) vs AN2 Therapeutics, Inc. (ANTX)

Alpha Cognition Inc. and AN2 Therapeutics, Inc. are both Biotechnology companies. Alpha Cognition Inc. and AN2 Therapeutics, Inc. are of similar size ($186.6M and $184.5M). AN2 Therapeutics, Inc. has the higher net margin (0.00% vs −137.7%) and the higher return on invested capital (0.00% vs −144.7%). Across the 13 metrics below, AN2 Therapeutics, Inc. leads on 8 and Alpha Cognition Inc. on 5.

Valuation

Metric ACOG ANTX Biotechnology median
P/E n/m n/m 7.88
P/S 12.08 n/m 11.47
P/B 3.48 2.88 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 9.44 n/m 10.73
Earnings yield (12.75%) (21.93%) (28.84%)
Free cash flow yield (20.11%) (14.05%) (23.03%)

Profitability

Metric ACOG ANTX Biotechnology median
Gross margin 90.37% 0.00% 65.16%
Operating margin (174.70%) 0.00% 0.00%
Net margin (137.69%) 0.00% 0.00%
Free cash flow margin (242.99%) 0.00% 0.00%
Return on equity (49.53%) (50.12%) (57.72%)
Return on assets (38.33%) (46.06%) (49.22%)
Return on invested capital (144.65%) 0.00% 0.00%

Growth

Metric ACOG ANTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 42.08% 32.56% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACOG ANTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.03 14.32 4.73
Net debt to EBITDA 2.92 1.48 0.96

Dividend

Metric ACOG ANTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ACOG ANTX Biotechnology median
Market cap 186.64m 184.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack